New IOL ideal for paediatric cataract procedures

Article

A novel, patented multi-component IOL (IVO Lens, InfinitVision Optics) allows for postoperative adjustments for changes in refraction, making it an ideal solution for paediatric cataract surgery, according to a recent report.

A novel, patented multi-component IOL (IVO Lens, InfinitVision Optics) allows for postoperative adjustments for changes in refraction, making it an ideal solution for paediatric cataract surgery, according to a report published in the January 2014 issue of the Journal of Refractive Surgery.

"Paediatric cataract surgery is essentially different from adult cataract surgery," wrote Dr Dimitra M. Portaliou and colleagues from the Institute of Vision and Optics at the University of Crete, Greece. "In paediatric cataract surgery, additional risks are present and postoperative complications may jeopardize and otherwise successful surgical intervention. One of the main considerations is the ongoing postoperative evolution of the power of IOL needed to correct children's eyes. A solution to the problem is provided by the development of the new, innovative, multicomponent InfiniteVision Optics IOL that will allow postoperative adjustments for postoperative changes in refraction," they wrote.

This lens remains adjustable throughout the patient’s lifetime, and allows for the addition and combination of presbyopic and astigmatic correction. It is comprised of two components: a base lens (posterior component) that has a platehaptic configuration, contains only spherical correction, and is implanted in a capsular bag, like a conventional posterior chamber IOL; and a front lens assembly with two haptics extending from the optic. These haptics have been designed to fit into two small bridges projecting off of the anterior surface of the base lens, securing both components together.

The front lens assembly allows for spherical, cylindrical, and multifocal primary corrections immediately and over time. The lens is implanted through a 1.8-mm to 2.8-mm incision, and is easily assembled inside the eye.

A feasibility study trial with the IVO lens included 6 eyes in 6 patients, with a mean age of 63.3 years. At 2 years' post-op, mean uncorrected visual acuity (from 9.11 to 0.68) and corrected distance visual acuity (from 0.28 to 0.83; P

For more information, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.